Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case report
Until recently, treatment options for patients with recurrent or metastatic endometrial cancer (EC) were limited. First-line treatment is usually based on carboplatin and paclitaxel and there was no standard second- line therapy following platinum failure. However, the introduction of immunotherapy...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2025-06-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/pseudoprogression-and-improvement-of-quality-of-life-in-a-patient-with-advanced-endometrial-cancer-treated-with-immunotherapy-a-case-report/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|